Chengdu Easton Biopharmaceuticals Co Ltd Cash Flow Quality Index
Chengdu Easton Biopharmaceuticals Co Ltd cash flow quality index. Chengdu Easton Biopharmaceuticals Co Ltd (688513) has a Cash Flow Quality Index of 0.73x as of September 2025. Operating cash flow of CN¥61.35 Million is below net income of CN¥83.59 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Chengdu Easton Biopharmaceuticals Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Chengdu Easton Biopharmaceuticals Co Ltd (2013–2025)
Cash flow quality index of Chengdu Easton Biopharmaceuticals Co Ltd from 2013 to 2025. Historical Cash Flow Quality Index for Chengdu Easton Biopharmaceuticals Co Ltd across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. See debt-free asset ratio of Chengdu Easton Biopharmaceuticals Co Ltd to measure how much of total assets are equity-financed.
Chengdu Easton Biopharmaceuticals Co Ltd Cash Flow Quality Index by Year (2013–2025)
Chengdu Easton Biopharmaceuticals Co Ltd cash flow quality index by year from 2013 to 2025. Year-by-year earnings quality comparison for Chengdu Easton Biopharmaceuticals Co Ltd. For the full cash flow conversion analysis, see Chengdu Easton Biopharmaceuticals Co Ltd (688513) cash conversion ratio.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.94x | CN¥264.94 Million | CN¥283.25 Million | ▼ -15.3% |
| 2024 | 1.10x | CN¥263.24 Million | CN¥238.23 Million | ▼ -9.0% |
| 2023 | 1.21x | CN¥275.25 Million | CN¥226.57 Million | ▲ +97.1% |
| 2022 | 0.62x | CN¥151.94 Million | CN¥246.52 Million | ▼ -2.9% |
| 2021 | 0.64x | CN¥147.60 Million | CN¥232.43 Million | ▼ -27.7% |
| 2020 | 0.88x | CN¥156.52 Million | CN¥178.16 Million | ▼ -32.7% |
| 2019 | 1.31x | CN¥141.83 Million | CN¥108.61 Million | ▲ +5.7% |
| 2018 | 1.24x | CN¥166.79 Million | CN¥135.02 Million | ▼ -7.2% |
| 2017 | 1.33x | CN¥85.70 Million | CN¥64.37 Million | ▼ -28.0% |
| 2016 | 1.85x | CN¥106.06 Million | CN¥57.32 Million | ▲ +37.7% |
| 2015 | 1.34x | CN¥50.57 Million | CN¥37.62 Million | ▼ -15.9% |
| 2014 | 1.60x | CN¥46.71 Million | CN¥29.23 Million | ▼ -16.3% |
| 2013 | 1.91x | CN¥28.12 Million | CN¥14.73 Million | — |